|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
| ||||||||||||||||||||
Files in this Data Supplement:
Fig. S1. BrdU staining (pink) in control and Lkb1−/− MEFs (passage 4) following a 6-hour BrdU pulse indicates 18.56% (s.d.=1.48) positive cells in controls and 18.94% (s.d.=2,84) in Lkb1−/− MEFs. Values are averages from two experiments using independent MEF cultures, where 900 nuclei per genotype were scored for BrdU staining.
Fig. S2. SMA immunofluorescence staining (A, red) of control and AMPKα1−/−;α2−/− MEFs demonstrating comparable myofibroblast differentiation. Nuclei are visualized with Hoechst (blue). (B) Western blotting analysis of AMPK, SMA and SM22 levels of control (C) and AMPKα1−/−;α2−/− (−/−) MEFs. Lanes have been reorganized as indicated by black bars. MEF cultures were generated through AdCRE infection of AMPKα1+/−;α2lox/+ (Control) and AMPKα1−/−;α2lox/lox (AMPKα1−/−;α2−/−) MEFs, respectively.
| ||||||||||||||||||||